Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations

Published:2018-04 Issue:4 Volume:1864 Page:1308-1318
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Cariello Marica,Piccinin Elena,Garcia-Irigoyen Oihane,Sabbà Carlo,Moschetta Antonio

Funder

Italian Association for Cancer Research

NR-NET FP7 Marie Curie ITN

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference149 articles.

1. Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease;Attinkara;BMC. Res. Notes,2012

2. Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCO(−)(3) output;Baghdasaryan;Hepatology,2011

3. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis;Baghdasaryan;J. Hepatol.,2016

4. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies;Barone;Hepatology,1996

5. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity;Beaudet;Biochemistry,1998

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gardenia jasminoides Ellis. Polysaccharides Alleviated Cholestatic Liver Injury by Increasing the Production of Butyric Acid and FXR Activation;Phytotherapy Research;2024-09-05

2. Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion;Journal of Lipid Research;2024-09

3. Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials;Expert Opinion on Emerging Drugs;2024-07-04

4. Obeticholic acid attenuates the intestinal barrier disruption in a rat model of short bowel syndrome;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

5. NR1H4 disease: rapidly progressing neonatal intrahepatic cholestasis and early death;Orphanet Journal of Rare Diseases;2024-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3